The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer
Abstract
Natural killer (NK) cells (CD56+/CD3–) in the circulation of cancer patients were reported to have low NK activity and undergo spontaneous apoptosis. A possible relationship between apoptosis and impaired NK activity was studied by Annexin V‐binding and NK‐cell assays performed with peripheral blood mononuclear cells of patients with head and neck cancer (HNC), breast cancer (BC) and normal controls (NC). Cells stained with Annexin V (Anx) and antibodies to CD56, CD3, CD95, CD25, CD122 or CD132 were examined by flow cytometry. NK activity was tested against K562 targets in 4‐h 51 Cr‐release assays. The ratio of CD56 dim/CD56 bright NK cells was significantly different in patients vs. controls (10 vs. 16; p<0.01). A significantly greater percentage of CD56 dim NK cells bound Anx in HNC patients (27±17%, median ± SD) or BC (46±18%) than in NC (15±18%, p<0.04and p<0.0002, respectively). CD56 dim NK cells were preferentially targeted for apoptosis. NK activity was significantly lower in patients with HNC and BC than in NC (p<0.009). An inverse correlation between NK activity and the percent of Anx+CD56 dim NK cells was observed in cancer patients (p =0.002) but not in NC. In patients, circulating CD56 dim NK cells were targeted for apoptosis, leading to low levels of NK activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Cited by
Immunology and Immunotherapy of Head and Neck Cancer
Ferris, R. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.1509 · Cited by 668
Kim, J. W., Wieckowski, E., Taylor, D. D., Reichert, T. E., Watkins, S., & Whiteside, T. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1010.11.3 · Cited by 497
Self-citationTurturici, G., Tinnirello, R., Sconzo, G., & Geraci, F. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2013 · Cited by 483
Human CD56bright NK Cells: An Update
Michel, T., Poli, A., Cuapio, A., Briquemont, B., Iserentant, G., Ollert, M., & Zimmer, J. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502570 · Cited by 395
Whiteside, T. L. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120265 · Cited by 388
Self-citation
Metadata
- Authors
- Bauernhofer, T., Kuss, I., Henderson, B., Baum, A. S., & Whiteside, T. L.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2002-12-20
- Volume
- 33
- Issue
- 1
- Pages
- 119-124
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2038723984
- Cited by
- 164
- References
- 1
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. https://app.cochat.ai/papers/10.1002/immu.200390014
- The paper
- Bauernhofer, T., Kuss, I., Henderson, B., Baum, A. S., & Whiteside, T. L. (2003). Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer. European Journal of Immunology. https://doi.org/10.1002/immu.200390014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.